Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: A systematic review of the current literature

Nitin Garg, Nikolaos Karagiorgos, George T. Pisimisis, Davendra P S Sohal, G Matthew Longo, Jason M Johanning, Thomas G. Lynch, Iraklis I Pipinos

Research output: Contribution to journalReview article

113 Citations (Scopus)

Abstract

Purpose: To compare through a systematic review of published literature the stroke outcomes in protected and unprotected carotid artery stenting (CAS). Methods: PubMed and Cochrane electronic databases were queried to identify peer-reviewed publications from 1995 to 2007 meeting our pre-defined criteria for inclusion (English language, human only, at least 20 patients reported) and exclusion (procedures performed for the treatment of total occlusion, dissection, or aneurysmal disease; urgently performed procedures; use of covered stents; access other than transfemoral). Information was collected on a standardized data abstraction form for pooled analysis of total strokes within 30 days of procedure in all patients and in symptomatic and asymptomatic subgroups. A random effects meta-analysis of studies with concurrently reported data on protected and unprotected CAS was performed. Results: Initial database query resulted in 2485 articles, of which 134 were included in the final analyses (12,263 protected CAS patients and 11,198 unprotected CAS patients). Twenty-four studies included data on both protected and unprotected CAS. Using pooled analysis of all 134 reports, the relative risk (RR) for stroke was 0.62 (95% CI 0.54 to 0.72) in favor of protected CAS. Subgroup analysis revealed a significant benefit for protected CAS in both symptomatic (RR 0.67; 95% CI 0.52 to 0.56) and asymptomatic (RR 0.61; 95% CI 0.41 to 0.90) patients (p<0.05). Meta-analysis of the 24 studies reporting data on both protected and unprotected stenting demonstrated a relative risk of 0.59 (95% CI 0.47 to 0.73) for stroke, again favoring protected CAS (p<0.001). Conclusion: Our systematic review indicated that the use of cerebral protection devices decreased the risk of perioperative stroke with CAS. A well designed randomized trial can further confirm our findings and possibly indicate the device with the best outcomes.

Original languageEnglish (US)
Pages (from-to)412-427
Number of pages16
JournalJournal of Endovascular Therapy
Volume16
Issue number4
DOIs
StatePublished - Aug 1 2009

Fingerprint

Angioplasty
Carotid Arteries
Stroke
Equipment and Supplies
Meta-Analysis
Databases
PubMed
Stents
Publications
Dissection
Research Design
Language

Keywords

  • Carotid angioplasty
  • Emboli protection device
  • Meta-analysis
  • Stenting
  • Stroke
  • Systematic review

ASJC Scopus subject areas

  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting : A systematic review of the current literature. / Garg, Nitin; Karagiorgos, Nikolaos; Pisimisis, George T.; Sohal, Davendra P S; Longo, G Matthew; Johanning, Jason M; Lynch, Thomas G.; Pipinos, Iraklis I.

In: Journal of Endovascular Therapy, Vol. 16, No. 4, 01.08.2009, p. 412-427.

Research output: Contribution to journalReview article

@article{81ddde99a6a74675b044b83cb2648b12,
title = "Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: A systematic review of the current literature",
abstract = "Purpose: To compare through a systematic review of published literature the stroke outcomes in protected and unprotected carotid artery stenting (CAS). Methods: PubMed and Cochrane electronic databases were queried to identify peer-reviewed publications from 1995 to 2007 meeting our pre-defined criteria for inclusion (English language, human only, at least 20 patients reported) and exclusion (procedures performed for the treatment of total occlusion, dissection, or aneurysmal disease; urgently performed procedures; use of covered stents; access other than transfemoral). Information was collected on a standardized data abstraction form for pooled analysis of total strokes within 30 days of procedure in all patients and in symptomatic and asymptomatic subgroups. A random effects meta-analysis of studies with concurrently reported data on protected and unprotected CAS was performed. Results: Initial database query resulted in 2485 articles, of which 134 were included in the final analyses (12,263 protected CAS patients and 11,198 unprotected CAS patients). Twenty-four studies included data on both protected and unprotected CAS. Using pooled analysis of all 134 reports, the relative risk (RR) for stroke was 0.62 (95{\%} CI 0.54 to 0.72) in favor of protected CAS. Subgroup analysis revealed a significant benefit for protected CAS in both symptomatic (RR 0.67; 95{\%} CI 0.52 to 0.56) and asymptomatic (RR 0.61; 95{\%} CI 0.41 to 0.90) patients (p<0.05). Meta-analysis of the 24 studies reporting data on both protected and unprotected stenting demonstrated a relative risk of 0.59 (95{\%} CI 0.47 to 0.73) for stroke, again favoring protected CAS (p<0.001). Conclusion: Our systematic review indicated that the use of cerebral protection devices decreased the risk of perioperative stroke with CAS. A well designed randomized trial can further confirm our findings and possibly indicate the device with the best outcomes.",
keywords = "Carotid angioplasty, Emboli protection device, Meta-analysis, Stenting, Stroke, Systematic review",
author = "Nitin Garg and Nikolaos Karagiorgos and Pisimisis, {George T.} and Sohal, {Davendra P S} and Longo, {G Matthew} and Johanning, {Jason M} and Lynch, {Thomas G.} and Pipinos, {Iraklis I}",
year = "2009",
month = "8",
day = "1",
doi = "10.1583/09-2713.1",
language = "English (US)",
volume = "16",
pages = "412--427",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "4",

}

TY - JOUR

T1 - Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting

T2 - A systematic review of the current literature

AU - Garg, Nitin

AU - Karagiorgos, Nikolaos

AU - Pisimisis, George T.

AU - Sohal, Davendra P S

AU - Longo, G Matthew

AU - Johanning, Jason M

AU - Lynch, Thomas G.

AU - Pipinos, Iraklis I

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Purpose: To compare through a systematic review of published literature the stroke outcomes in protected and unprotected carotid artery stenting (CAS). Methods: PubMed and Cochrane electronic databases were queried to identify peer-reviewed publications from 1995 to 2007 meeting our pre-defined criteria for inclusion (English language, human only, at least 20 patients reported) and exclusion (procedures performed for the treatment of total occlusion, dissection, or aneurysmal disease; urgently performed procedures; use of covered stents; access other than transfemoral). Information was collected on a standardized data abstraction form for pooled analysis of total strokes within 30 days of procedure in all patients and in symptomatic and asymptomatic subgroups. A random effects meta-analysis of studies with concurrently reported data on protected and unprotected CAS was performed. Results: Initial database query resulted in 2485 articles, of which 134 were included in the final analyses (12,263 protected CAS patients and 11,198 unprotected CAS patients). Twenty-four studies included data on both protected and unprotected CAS. Using pooled analysis of all 134 reports, the relative risk (RR) for stroke was 0.62 (95% CI 0.54 to 0.72) in favor of protected CAS. Subgroup analysis revealed a significant benefit for protected CAS in both symptomatic (RR 0.67; 95% CI 0.52 to 0.56) and asymptomatic (RR 0.61; 95% CI 0.41 to 0.90) patients (p<0.05). Meta-analysis of the 24 studies reporting data on both protected and unprotected stenting demonstrated a relative risk of 0.59 (95% CI 0.47 to 0.73) for stroke, again favoring protected CAS (p<0.001). Conclusion: Our systematic review indicated that the use of cerebral protection devices decreased the risk of perioperative stroke with CAS. A well designed randomized trial can further confirm our findings and possibly indicate the device with the best outcomes.

AB - Purpose: To compare through a systematic review of published literature the stroke outcomes in protected and unprotected carotid artery stenting (CAS). Methods: PubMed and Cochrane electronic databases were queried to identify peer-reviewed publications from 1995 to 2007 meeting our pre-defined criteria for inclusion (English language, human only, at least 20 patients reported) and exclusion (procedures performed for the treatment of total occlusion, dissection, or aneurysmal disease; urgently performed procedures; use of covered stents; access other than transfemoral). Information was collected on a standardized data abstraction form for pooled analysis of total strokes within 30 days of procedure in all patients and in symptomatic and asymptomatic subgroups. A random effects meta-analysis of studies with concurrently reported data on protected and unprotected CAS was performed. Results: Initial database query resulted in 2485 articles, of which 134 were included in the final analyses (12,263 protected CAS patients and 11,198 unprotected CAS patients). Twenty-four studies included data on both protected and unprotected CAS. Using pooled analysis of all 134 reports, the relative risk (RR) for stroke was 0.62 (95% CI 0.54 to 0.72) in favor of protected CAS. Subgroup analysis revealed a significant benefit for protected CAS in both symptomatic (RR 0.67; 95% CI 0.52 to 0.56) and asymptomatic (RR 0.61; 95% CI 0.41 to 0.90) patients (p<0.05). Meta-analysis of the 24 studies reporting data on both protected and unprotected stenting demonstrated a relative risk of 0.59 (95% CI 0.47 to 0.73) for stroke, again favoring protected CAS (p<0.001). Conclusion: Our systematic review indicated that the use of cerebral protection devices decreased the risk of perioperative stroke with CAS. A well designed randomized trial can further confirm our findings and possibly indicate the device with the best outcomes.

KW - Carotid angioplasty

KW - Emboli protection device

KW - Meta-analysis

KW - Stenting

KW - Stroke

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=70350145616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350145616&partnerID=8YFLogxK

U2 - 10.1583/09-2713.1

DO - 10.1583/09-2713.1

M3 - Review article

C2 - 19702342

AN - SCOPUS:70350145616

VL - 16

SP - 412

EP - 427

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 4

ER -